Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2013 2
2014 2
2015 4
2016 3
2017 2
2018 3
2019 3
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
Sjoquist KM, Renfro LA, Simes RJ, Tebbutt NC, Clarke S, Seymour MT, Adams R, Maughan TS, Saltz L, Goldberg RM, Schmoll HJ, Van Cutsem E, Douillard JY, Hoff PM, Hecht JR, Tournigand C, Punt CJA, Koopman M, Hurwitz H, Heinemann V, Falcone A, Porschen R, Fuchs C, Diaz-Rubio E, Aranda E, Bokemeyer C, Souglakos I, Kabbinavar FF, Chibaudel B, Meyers JP, Sargent DJ, de Gramont A, Zalcberg JR; Fondation Aide et Recherche en Cancerologie Digestive Group (ARCAD). Sjoquist KM, et al. J Natl Cancer Inst. 2018 Jun 1;110(6):638-648. doi: 10.1093/jnci/djx253. J Natl Cancer Inst. 2018. PMID: 29267900 Free PMC article. Clinical Trial.
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.
Pavlakis N, Sjoquist KM, Martin AJ, Tsobanis E, Yip S, Kang YK, Bang YJ, Alcindor T, O'Callaghan CJ, Burnell MJ, Tebbutt NC, Rha SY, Lee J, Cho JY, Lipton LR, Wong M, Strickland A, Kim JW, Zalcberg JR, Simes J, Goldstein D. Pavlakis N, et al. Among authors: sjoquist km. J Clin Oncol. 2016 Aug 10;34(23):2728-35. doi: 10.1200/JCO.2015.65.1901. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325864 Free PMC article. Clinical Trial.
Challenges of international oncology trial collaboration-a call to action.
Tang M, Joensuu H, Simes RJ, Price TJ, Yip S, Hague W, Sjoquist KM, Zalcberg J. Tang M, et al. Among authors: sjoquist km. Br J Cancer. 2019 Oct;121(7):515-521. doi: 10.1038/s41416-019-0532-4. Epub 2019 Aug 5. Br J Cancer. 2019. PMID: 31378784 Free PMC article. Review.
NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121).
McNamara MG, Goyal L, Doherty M, Springfeld C, Cosgrove D, Sjoquist KM, Park JO, Verdaguer H, Braconi C, Ross PJ, Gramont A, Zalcberg JR, Palmer DH, Valle JW, Knox JJ. McNamara MG, et al. Among authors: sjoquist km. Future Oncol. 2020 Jun;16(16):1069-1081. doi: 10.2217/fon-2020-0247. Epub 2020 May 6. Future Oncol. 2020. PMID: 32374623 Clinical Trial.
Clinical utility of ramucirumab in advanced gastric cancer.
Chan MM, Sjoquist KM, Zalcberg JR. Chan MM, et al. Among authors: sjoquist km. Biologics. 2015 Sep 22;9:93-105. doi: 10.2147/BTT.S62777. eCollection 2015. Biologics. 2015. PMID: 26451083 Free PMC article. Review.
Personalising pancreas cancer treatment: When tissue is the issue.
Sjoquist KM, Chin VT, Chantrill LA, O'Connor C, Hemmings C, Chang DK, Chou A, Pajic M, Johns AL, Nagrial AM, Biankin AV, Yip D. Sjoquist KM, et al. World J Gastroenterol. 2014 Jun 28;20(24):7849-63. doi: 10.3748/wjg.v20.i24.7849. World J Gastroenterol. 2014. PMID: 24976722 Free PMC article. Review.
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903.
Mileshkin L, Edmondson R, O'Connell RL, Sjoquist KM, Andrews J, Jyothirmayi R, Beale P, Bonaventura T, Goh J, Hall M, Clamp A, Green J, Lord R, Amant F, Alexander L, Carty K, Paul J, Scurry J, Millan D, Nottley S, Friedlander M; PARAGON study group. Mileshkin L, et al. Among authors: sjoquist km. Gynecol Oncol. 2019 Jul;154(1):29-37. doi: 10.1016/j.ygyno.2019.05.007. Epub 2019 May 23. Gynecol Oncol. 2019. PMID: 31130288 Clinical Trial.
Gastric cancer: past progress and present challenges.
Sjoquist KM, Zalcberg JR. Sjoquist KM, et al. Gastric Cancer. 2015 Apr;18(2):205-9. doi: 10.1007/s10120-014-0437-0. Epub 2014 Oct 26. Gastric Cancer. 2015. PMID: 25344928 No abstract available.
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Tang M, O'Connell RL, Amant F, Beale P, McNally O, Sjoquist KM, Grant P, Davis A, Sykes P, Mileshkin L, Moujaber T, Kennedy CJ, deFazio A, Tan K, Antill Y, Goh J, Bonaventura T, Scurry J, Friedlander M. Tang M, et al. Among authors: sjoquist km. Gynecol Oncol. 2019 Sep;154(3):531-538. doi: 10.1016/j.ygyno.2019.06.011. Epub 2019 Jun 18. Gynecol Oncol. 2019. PMID: 31227223 Clinical Trial.
23 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page